1. 42288-26-6
2. 2-(4-cyanophenylamino)acetic Acid
3. 2-((4-cyanophenyl)amino)acetic Acid
4. N-(4-cyano-phenyl)-glycine
5. N-(4-cyanophenyl)-glycine
6. 2-(4-cyanoanilino)acetic Acid
7. 2-[(4-cyanophenyl)amino]acetic Acid
8. Glycine, N-(4-cyanophenyl)-
9. Mfcd01464022
10. [(4-cyanophenyl)amino]acetic Acid
11. N-(p-cyanophenyl)-glycine
12. Oprea1_114543
13. Schembl361315
14. (4-cyano-phenylamino)acetic Acid
15. Dtxsid80355883
16. Zinc332337
17. (4-cyano-phenylamino)-acetic Acid
18. Bcp04527
19. Cs-d0913
20. 2-(4-cyanophenylamino) Acetic Acid
21. Sc3501
22. Akos000218605
23. Ac-7903
24. Fs-3199
25. Hy-77519
26. Sy021403
27. Db-003865
28. Am20090750
29. Bb 0253985
30. Ft-0647115
31. En300-52080
32. 288c266
33. Q-102527
Molecular Weight | 176.17 g/mol |
---|---|
Molecular Formula | C9H8N2O2 |
XLogP3 | 0.3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 176.058577502 g/mol |
Monoisotopic Mass | 176.058577502 g/mol |
Topological Polar Surface Area | 73.1 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 223 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
BUILDING BLOCK
Aptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.
A fully integrated & globally specialized company in the development, production & marketing of APIs.
Aptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
Aptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
Aptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.
Aptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.
SS Pharma is focused on developing & manufacturing registered Intermediates, APIs, Fine Chemicals & Pyridine Derivatives.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
Aptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.